$LXRX·4

LEXICON PHARMACEUTICALS, INC./DE · Feb 10, 4:12 PM ET

LEXICON PHARMACEUTICALS, INC./DE 4

4 · LEXICON PHARMACEUTICALS, INC./DE · Filed Feb 10, 2014

Insider Transaction Report

Form 4
Period: 2014-02-06
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
Transactions
  • Award

    Restricted Stock Units (Phantom Stock)

    2014-02-06+85,00085,000 total
    Common Stock (85,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2014-02-06+340,000340,000 total
    Exercise: $1.72Exp: 2024-02-06Common Stock (340,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2015 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
  • [F3]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/6/15) and vests 1/48th per month for each month of service thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT